Northwest Biotherapeutics, Inc.

OTC:NWBO

0.82315 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 1.9321.6831.0051.2912.410.4120.3360.6231.7391.4540.8090.7720.010.010.010.010.010.80.1240.390.5290.0090.1290.1560.210.390.480.23
Cost of Revenue 27.731.54820.30833.63714.10618.15433.51560.081103.1285.63743.90628.90800000.0120.010.0120.040.0790.0070.0670.0510.050.0800
Gross Profit -25.7980.135-19.303-32.346-11.696-17.742-33.179-59.458-101.381-84.183-43.097-28.1360.010.010.010.01-0.0020.790.1120.350.450.0020.0630.1050.160.310.480.23
Gross Profit Ratio -13.3530.08-19.207-25.055-4.853-43.063-98.747-95.438-58.298-57.898-53.272-36.4461111-0.20.9880.9030.8970.8510.2220.4830.6740.7620.79511
Reseach & Development Expenses 27.7335.51120.30833.63713.5918.15433.51560.081103.1285.63743.90628.90813.4529.8999.58812.7038.7783.7774.4693.6211.6245.9564.9083.1142.892.861.970.66
General & Administrative Expenses 29.7133.35333.39954.25916.28327.01521.49919.80824.90316.94912.36415.67513.3355.4635.7998.9067.1712.2732.0052.8454.0597.4634.7593.6822.541.770.880.7
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 29.7133.35333.39954.25916.28327.01521.49919.80824.90316.94912.36415.67513.3355.4635.7998.9067.1712.2732.0052.8454.0597.4634.7593.6822.541.770.880.7
Other Expenses 00.033-0.647000-2.297-5.680-18.905-10.63-11.1450.010.0020.0070.0220.0070.7470.0630.2621.2852.3460.4670.1990.180.160.140.1
Operating Expenses 57.4468.86453.70787.89629.87345.16955.01479.889128.023102.59756.28244.59726.79715.36415.39421.63115.9566.7976.5376.7286.96815.76510.1336.9955.614.792.991.46
Operating Income -55.508-67.181-52.702-86.605-27.463-41.481-54.678-79.266-126.284-101.143-57.473-43.825-26.787-15.354-15.773-21.621-15.958-5.997-6.425-6.378-6.518-15.763-10.071-6.89-5.45-4.48-2.51-1.23
Operating Income Ratio -28.731-39.917-52.44-67.084-11.395-100.682-162.732-127.233-72.619-69.562-71.042-56.768-2,678.7-1,535.4-1,577.3-2,162.1-1,595.8-7.496-51.815-16.354-12.321-1,751.444-77.798-44.175-25.952-11.487-5.229-5.348
Total Other Income Expenses Net -7.091-37.851231.828-443.2167.1675.687-18.465-0.94811.543-34.491-10.315-23.495-6.043-12.014-9.498-0.71-5.2894.602-3.512-2.130.7662.959-869.1510-0.16-0.24-0.050
Income Before Tax -62.599-105.032179.126-529.821-20.296-35.794-73.143-80.214-114.741-135.634-65.789-67.32-32.83-27.368-25.271-22.331-21.247-1.395-9.937-8.508-5.752-12.804-10,939.7640-5.61-4.72-2.56-1.23
Income Before Tax Ratio -32.401-62.408178.235-410.396-8.422-86.879-217.688-128.754-65.981-93.283-81.321-87.202-3,283-2,736.8-2,527.1-2,233.1-2,124.7-1.744-80.137-21.815-10.873-1,422.667-84,512.1830-26.714-12.103-5.333-5.348
Income Tax Expense 031.8164.3648.5443.27615.5583.248-1.8624.153-17.909-9.7872.2976.04312.0149.8870.710.01-4.60202.13-0.766-2.959-868.2825.89-0.32-0.4700
Net Income -62.599-136.848179.126-538.365-23.572-35.794-73.143-80.214-114.741-135.634-65.789-67.32-32.83-27.368-25.271-22.331-21.257-1.395-9.937-8.508-5.752-12.804-10.94-12.779-5.61-4.72-2.56-1.23
Net Income Ratio -32.401-81.312178.235-417.014-9.781-86.879-217.688-128.754-65.981-93.283-81.321-87.202-3,283-2,736.8-2,527.1-2,233.1-2,125.7-1.744-80.137-21.815-10.873-1,422.667-84.512-81.938-26.714-12.103-5.333-5.348
EPS -0.058-0.130.21-0.74-0.042-0.081-0.3-0.72-1.48-2.29-2-5.72-5.58-6.53-8.43-8.42-13.93-6.27-125.07-107.31-73.01-181.71-997.97-1,474.3-561-472-256-123
EPS Diluted -0.058-0.13-0.06-0.74-0.042-0.081-0.3-0.72-1.48-2.29-2-5.72-5.58-6.53-8.43-8.42-13.93-6.27-125.07-107.31-73.01-181.71-997.97-1,474.3-561-472-256-123
EBITDA -55.508-97.416184.723-520.852-17.816-24.623-67.159-76.207-110.532-134.627-64.904-51.822-25.172-15.352-15.766-21.599-10.189-5.96-3.454-4.687-6.269-15.17-8.923-1.303-5.57-4.79-2.61-1.23
EBITDA Ratio -28.731-39.007-52.5-66.754-11.395-105.5-168.262-136.047-72.587-82.556-81.695-71.187-2,838.2-1,073.3-937.1-2,123.9-1,018.9-13.886-27.855-10.741-11.355-1,806.333-68.931-8.357-26.524-12.282-5.438-5.348